Susquehanna Fundamental Investments, LLC Personalis, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.89 - $5.32 $183,607 - $337,990	-63,532 Reduced 61.44%	39,879 $118,000
Q1 2022 May 16, 2022	BUY	$7.56 - $14.3 $205,745 - $389,174	27,215 Added 35.72%	103,411 $847,000
Q4 2021 Feb 14, 2022	BUY	$12.24 - $21.25 $130,258 - $226,142	10,642 Added 16.23%	76,196 $1.09 Million
Q3 2021 Nov 15, 2021	BUY	$16.69 - $26.05 $362,790 - $566,248	21,737 Added 49.61%	65,554 $1.26 Million
Q2 2021 Aug 11, 2021	BUY	$18.15 - $27.75 $795,278 - $1.22 Million	43,817 New	43,817 $1.11 Million

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $180M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.